159 related articles for article (PubMed ID: 27749742)
1. Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancer.
Ruan X; Zhang Y; Mueck AO; Willibald M; Seeger H; Fehm T; Brucker S; Neubauer H
Menopause; 2017 Feb; 24(2):203-209. PubMed ID: 27749742
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma.
Tsai HW; Ho CL; Cheng SW; Lin YJ; Chen CC; Cheng PN; Yen CJ; Chang TT; Chiang PM; Chan SH; Ho CH; Chen SH; Wang YW; Chow NH; Lin JC
World J Gastroenterol; 2018 Mar; 24(10):1152-1166. PubMed ID: 29563759
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
Neubauer H; Clare SE; Wozny W; Schwall GP; Poznanovic S; Stegmann W; Vogel U; Sotlar K; Wallwiener D; Kurek R; Fehm T; Cahill MA
Breast Cancer Res; 2008; 10(5):R85. PubMed ID: 18922159
[TBL] [Abstract][Full Text] [Related]
4. [Expression of progesterone receptor membrane component-1 is associated with the malignant phenotypes of breast cancer].
Ji S; Wu A; Yang H
Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):635-8. PubMed ID: 22588913
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression.
Asperger H; Stamm N; Gierke B; Pawlak M; Hofmann U; Zanger UM; Marton A; Katona RL; Buhala A; Vizler C; Cieslik JP; Ruckhäberle E; Niederacher D; Fehm T; Neubauer H; Ludescher M
Breast Cancer Res; 2020 Jul; 22(1):75. PubMed ID: 32660617
[TBL] [Abstract][Full Text] [Related]
6. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
[TBL] [Abstract][Full Text] [Related]
7. PGRMC1: a new biomarker for the estrogen receptor in breast cancer.
Craven RJ
Breast Cancer Res; 2008; 10(6):113. PubMed ID: 19090968
[TBL] [Abstract][Full Text] [Related]
8. Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.
Ruan X; Gu M; Cai G; Zhao Y; Wang L; Li X; Mueck AO
Maturitas; 2019 May; 123():1-8. PubMed ID: 31027671
[TBL] [Abstract][Full Text] [Related]
9. High Level of Progesteron Receptor Membrane Component 1 (PGRMC 1) in Tissue of Breast Cancer Patients is Associated with Worse Response to Anthracycline-Based Neoadjuvant Therapy.
Willibald M; Wurster I; Meisner C; Vogel U; Seeger H; Mueck AO; Fehm T; Neubauer H
Horm Metab Res; 2017 Aug; 49(8):595-603. PubMed ID: 28701017
[TBL] [Abstract][Full Text] [Related]
10. Absence of progesterone receptor membrane component 1 reduces migration and metastasis of breast cancer.
Lee SR; Lee YH; Jo SL; Heo JH; Kim G; Lee GS; An BS; Baek IJ; Hong EJ
Cell Commun Signal; 2021 Apr; 19(1):42. PubMed ID: 33832499
[TBL] [Abstract][Full Text] [Related]
11. Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with PGRMC1 expression in breast tumour tissue and with clinical breast tumour characteristics.
Cai G; Yang X; Ruan X; Wang J; Fang Y; Wei Y; Zhang Y; Gu M; Mueck AO
Maturitas; 2020 Oct; 140():64-71. PubMed ID: 32972637
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between progesterone receptor membrane component 1 and estrogen receptor α promotes breast cancer cell proliferation.
Pedroza DA; Subramani R; Tiula K; Do A; Rashiraj N; Galvez A; Chatterjee A; Bencomo A; Rivera S; Lakshmanaswamy R
Lab Invest; 2021 Jun; 101(6):733-744. PubMed ID: 33903732
[TBL] [Abstract][Full Text] [Related]
13. Possible role of PGRMC1 in breast cancer development.
Neubauer H; Ma Q; Zhou J; Yu Q; Ruan X; Seeger H; Fehm T; Mueck AO
Climacteric; 2013 Oct; 16(5):509-13. PubMed ID: 23758160
[TBL] [Abstract][Full Text] [Related]
14. The presence of a membrane-bound progesterone receptor induces growth of breast cancer with norethisterone but not with progesterone: A xenograft model.
Zhao Y; Ruan X; Wang H; Li X; Gu M; Wang L; Li Y; Seeger H; Mueck AO
Maturitas; 2017 Aug; 102():26-33. PubMed ID: 28610679
[TBL] [Abstract][Full Text] [Related]
15. May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer?
Zhang Y; Ruan X; Willibald M; Seeger H; Fehm T; Neubauer H; Mueck AO
Gynecol Endocrinol; 2016; 32(1):58-60. PubMed ID: 26303031
[TBL] [Abstract][Full Text] [Related]
16. Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with breast tumor characteristics and comparison with known tumor markers.
Ruan X; Cai G; Wei Y; Gu M; Zhang Y; Zhao Y; Mueck AO
Menopause; 2020 Feb; 27(2):183-193. PubMed ID: 31876619
[TBL] [Abstract][Full Text] [Related]
17. The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells.
Neubauer H; Yang Y; Seeger H; Fehm T; Cahill MA; Tong X; Ruan X; Mueck AO
Menopause; 2011 Aug; 18(8):845-50. PubMed ID: 21532513
[TBL] [Abstract][Full Text] [Related]
18. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy.
Neubauer H; Ruan X; Schneck H; Seeger H; Cahill MA; Liang Y; Mafuvadze B; Hyder SM; Fehm T; Mueck AO
Menopause; 2013 May; 20(5):504-10. PubMed ID: 23615641
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of forkhead box M1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer.
Ahn H; Sim J; Abdul R; Chung MS; Paik SS; Oh YH; Park CK; Jang K
J Korean Med Sci; 2015 Apr; 30(4):390-7. PubMed ID: 25829806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
